Jump Capital

Balto Software Inc. is a company that specializes in developing sales software utilizing artificial intelligence and real-time conversation analytics to enhance the performance of sales representatives during phone calls. Founded in 2017 and based in Saint Louis, Missouri, Balto's platform provides live guidance by listening to both sides of a conversation and offering prompts to agents, enabling them to address objections, recognize buyer signals, and maintain an effective dialogue. The software alerts representatives to errors in real-time, allowing for immediate self-correction and ensuring compliance with industry standards. Additionally, it automatically populates dashboards with detailed conversation data for managerial review, helping to identify areas for improvement. Balto's solutions cater to various sectors, including sales leadership, customer service, and compliance, ultimately aiming to improve conversion rates and enhance customer experiences.

Balto Software Inc. is a company that specializes in developing sales software utilizing artificial intelligence and real-time conversation analytics to enhance the performance of sales representatives during phone calls. Founded in 2017 and based in Saint Louis, Missouri, Balto's platform provides live guidance by listening to both sides of a conversation and offering prompts to agents, enabling them to address objections, recognize buyer signals, and maintain an effective dialogue. The software alerts representatives to errors in real-time, allowing for immediate self-correction and ensuring compliance with industry standards. Additionally, it automatically populates dashboards with detailed conversation data for managerial review, helping to identify areas for improvement. Balto's solutions cater to various sectors, including sales leadership, customer service, and compliance, ultimately aiming to improve conversion rates and enhance customer experiences.

MediBeacon Inc. specializes in real-time kidney function monitoring solutions, focusing on advancing nephrology through innovative optical diagnostic technology. The company has developed the NIC-Kidney device, which enables monitoring of the glomerular filtration rate in preclinical settings, and the MediBeacon renal function system, which utilizes an optical skin sensor along with a proprietary agent that illuminates under light. This system allows for continuous real-time monitoring of kidney function, providing clinicians with critical data to enhance patient care. Additionally, MediBeacon's product pipeline includes a range of light-activated agents designed for physiological monitoring and surgical guidance. Founded in 2012 and headquartered in St. Louis, Missouri, MediBeacon aims to improve patient outcomes in intensive care units and operating rooms through its innovative approaches to organ function measurement and management.